Inspire Pharma (ISPH) posts Q3 Loss of $0.12, Bests By 3c
Inspire Pharmaceuticals (NASDAQ: ISPH) reports Q3 loss of $0.12, 3 cents better than the analyst estimate of ($0.15). Revenue for the quarter was $25.20 million, which compares to the estimate of $23.68 million.
You May Also Be Interested In
- UPDATE: Youku.com (YOKU) Misses Q1 EPS by 1c; Sees Q2 Sales Up 90-100% YoY
- Pacific Sunwear Of California (PSUN) Tops Q1 EPS by 9c; Guides In-line
- Raven Industries, Inc. (RAVN) Tops Q1 EPS by 15c; Sees Meeting LT Earnings Growth Target
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
